About Pharmathen
Pharmathen: A Leading Pharmaceutical Company Focused on Innovation
Pharmathen is a research-centered pharmaceutical company that specializes in developing innovative generic products. With a focus on providing integrated services to its partners worldwide, Pharmathen has established itself as a leading player in the global pharmaceutical industry.
Founded in 1969, Pharmathen has grown into a multinational corporation with operations spanning across Europe, Asia, and the Americas. The company's success can be attributed to its unwavering commitment to innovation and quality.
At Pharmathen, innovation is at the heart of everything we do. Our team of experienced researchers and scientists work tirelessly to develop new products that meet the evolving needs of patients around the world. We invest heavily in research and development (R&D) activities to ensure that our products are safe, effective, and affordable.
In addition to R&D activities, Pharmathen also provides a complete package of integrated services including finished products, know-how, technological support and regulatory support. This comprehensive approach allows us to offer our partners customized solutions that meet their specific needs.
Our finished product portfolio includes over 2000 different formulations covering various therapeutic areas such as cardiovascular diseases, central nervous system disorders (CNS), oncology/hematology diseases etc., which are marketed under our own brand names or licensed out globally under partner brands.
Pharmathen's know-how covers all aspects of drug development from pre-formulation studies through clinical trials up until commercialization stage. Our technological support includes state-of-the-art manufacturing facilities equipped with advanced technologies such as continuous manufacturing systems for oral solid dosage forms (OSD), high containment facilities for handling potent compounds etc., which enable us to produce high-quality products efficiently at scale.
Regulatory compliance is an integral part of our business model at Pharmathen. We have extensive experience working with regulatory authorities around the world including FDA (USA), EMA (Europe), PMDA (Japan), ANVISA (Brazil) etc., and have a proven track record of successfully obtaining marketing authorizations for our products in various markets.
At Pharmathen, we are committed to sustainability and social responsibility. We strive to minimize our environmental impact by implementing eco-friendly practices throughout our operations. We also support various social initiatives aimed at improving the health and well-being of communities around the world.
In conclusion, Pharmathen is a leading pharmaceutical company that is dedicated to innovation, quality, and sustainability. With a comprehensive package of integrated services including finished products, know-how, technological support and regulatory compliance expertise, we are well-positioned to meet the evolving needs of our partners worldwide.